North America Neurovascular Devices Market Size & Outlook

The neurovascular devices market in North America is expected to reach a projected revenue of US$ 3,064.6 million by 2033. A compound annual growth rate of 4.8% is expected of North America neurovascular devices market from 2025 to 2033.
Revenue, 2024 (US$M)
$2,010.6
Forecast, 2033 (US$M)
$3,064.6
CAGR, 2025 - 2033
4.8%
Report Coverage
North America

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

North America neurovascular devices market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

North America neurovascular devices market highlights

  • The North America neurovascular devices market generated a revenue of USD 2,010.6 million in 2024.
  • The market is expected to grow at a CAGR of 4.8% from 2025 to 2033.
  • In terms of segment, cerebral embolization and aneurysm coiling devices was the largest revenue generating device type in 2024.
  • Neurothrombectomy Devices is the most lucrative device type segment registering the fastest growth during the forecast period.
  • Country-wise, Canada is expected to register the highest CAGR from 2025 to 2033.


North America data book summary

Market revenue in 2024USD 2,010.6 million
Market revenue in 2033USD 3,064.6 million
Growth rate4.8% (CAGR from 2025 to 2033)
Largest segmentCerebral embolization and aneurysm coiling devices
Fastest growing segmentNeurothrombectomy Devices
Historical data covered2021 - 2023
Base year for estimation2024
Forecast period covered2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationCerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices
Key market players worldwideMedtronic PLC, Johnson & Johnson, Penumbra Inc, MicroPort Scientific Corp, Stryker Corp, Terumo Corp, Integra Lifesciences Holdings Corp, Acandis GmbH, Spiegelberg, Zylox


Other key industry trends

  • In terms of revenue, North America region accounted for 27.4% of the global neurovascular devices market in 2024.
  • Globally, Europe is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 3,074.9 million by 2033.

Cerebral embolization and aneurysm coiling devices was the largest segment with a revenue share of 36.29% in 2024. Horizon Databook has segmented the North America neurovascular devices market based on cerebral embolization and aneurysm coiling devices, cerebral angioplasty and stenting systems, neurothrombectomy devices, support devices, trans radial access devices covering the revenue growth of each sub-segment from 2021 to 2033.


North America dominated the neurovascular devices market with the largest revenue share of 26.65% in 2021 owing to an increase in the prevalence of various neurovascular disorders such as, stroke & brain aneurysms as well as rise in the demand for minimally invasive neurological procedures.

Supportive government initiatives, including the establishment of American Society of Craniofacial Surgery (ASCFS), for creating awareness about minimally invasive Craniomaxillofacial (CMF) surgeries are expected to further propel the market during the forecast period. 

Moreover, rapid technological advancements, presence of key manufacturers in the region, increase in R&D investments, and rise in the number of government funding and initiatives. For instance, the National Parkinson Foundation (NPF) provides funds to researchers and scientists with an aim to make advancements in this field. 

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Neurovascular Devices Market Companies

Name Profile # Employees HQ Website
Zylox View profile 501-1000 Hangzhou, Zhejiang, China, Asia http://www.zyloxmedical.com/
Acandis GmbH View profile 251-500 Pforzheim, Baden-Wurttemberg, Germany, Europe https://www.acandis.com/start-1-en
Spiegelberg View profile 11-50 Hamburg, Hamburg, Germany, Europe https://www.spiegelberg.de/en/
Penumbra Inc View profile 4200 One Penumbra Place, Alameda, CA, United States, 94502 https://www.penumbrainc.com
MicroPort Scientific Corp View profile 8230 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai, China, People's Republic of, 201203 https://www.microport.com
Terumo Corp View profile 30207 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 https://www.terumo.com
Integra Lifesciences Holdings Corp View profile 3946 1100 Campus Road, Princeton, NJ, United States, 08540 https://www.integralife.com
Stryker Corp View profile 52000 1941 Stryker Way, Portage, MI, United States, 49002 https://www.stryker.com
Medtronic PLC View profile 95000 Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 https://www.medtronic.com
Johnson & Johnson View profile 134400 One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 https://www.jnj.com

North America neurovascular devices market size, by country, 2021-2033 (US$M)

North America Neurovascular Devices Market Outlook Share, 2024 & 2033 (US$M)

North America neurovascular devices market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online